SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009978
Filing Date
2019-11-05
Accepted
2019-11-05 16:25:14
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20190930x10q.htm 10-Q 2640570
2 EX-10.1 knsa-20190930ex101435496.htm EX-10.1 22892
3 EX-31.1 knsa-20190930ex311607157.htm EX-31.1 12911
4 EX-31.2 knsa-20190930ex312e04426.htm EX-31.2 11756
5 EX-32.1 knsa-20190930ex32125faf0.htm EX-32.1 7085
6 EX-32.2 knsa-20190930ex32238f8b2.htm EX-32.2 6979
  Complete submission text file 0001558370-19-009978.txt   7654774

Data Files

Seq Description Document Type Size
7 EX-101.INS knsa-20190930.xml EX-101.INS 1239186
8 EX-101.SCH knsa-20190930.xsd EX-101.SCH 55523
9 EX-101.CAL knsa-20190930_cal.xml EX-101.CAL 45682
10 EX-101.DEF knsa-20190930_def.xml EX-101.DEF 261739
11 EX-101.LAB knsa-20190930_lab.xml EX-101.LAB 481761
12 EX-101.PRE knsa-20190930_pre.xml EX-101.PRE 401128
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 191193671
SIC: 2834 Pharmaceutical Preparations